Wellington Pereira Yamaguti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wellington Pereira Yamaguti has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
Christina May Moran de Brito
Rehabilitation Service, Hospital Sírio-Libanês, São Paulo, Brazil
7 shared publicationsRenato Fraga Righetti
Rehabilitation Service, Hospital Sírio-Libanês, São Paulo, SP, Brazil
6 shared publicationsSamantha Torres Grams
PhD in health sciences; Senior Physiotherapist at Sírio-Libanês Hospital
6 shared publications- Elaine Paulin
UDESC
5 shared publications Igor Gutierrez Moraes
Hospital Sírio-Libanês, Rehabilitation Service, São Paulo, Brazil
5 shared publications- Davi de Souza Francisco
Hospital Sírio-Libanês, Brazil
4 shared publications
Latest Publications
- Open Access
- 27 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0347493
Effects of transcutaneous electrical phrenic nerve stimulation and transcutaneous electrical diaphragmatic stimulation: A protocol for a randomized, single-blind, crossover trial
Background: Patients in the intensive care unit (ICU) are at high risk of developing respiratory muscle weakness, which may lead to prolonged mechanical ventilation and worsening clinical outcomes. Noninvasive neuromuscular electrical stimulation techniques, such as transcutaneous electrical phrenic nerve stimulation (TEPNS) and transcutaneous diaphragmatic electrical stimulation (TDES), offer potential therapeutic options for patients unable to generate voluntary active contractions. However, there is limited research directly comparing the effects of these modalities on diaphragmatic function. The primary objective of this study is to evaluate the effects of TEPNS and TDES on diaphragmatic function in healthy adults. Secondary objectives include assessing the safety, feasibility, and perceived discomfort associated with the application of each technique. Methods: This study will be a bicentric, randomized, single-blind, crossover trial that will be conducted at two hospitals in São Paulo, Brazil. Healthy adults aged 18–60, with a BMI between 18.5 and 24.9 kg/m 2 , no history of respiratory diseases, and no contraindications for the proposed electrical stimulation modalities will be included. Diaphragm thickness, thickening fraction, and mobility will be assessed using ultrasound during tidal breathing. Participants will be randomly assigned to begin the intervention with one of two experimental conditions: (1) TEPNS protocol or (2) TDES protocol. In addition, data on the safety and feasibility of each electrical stimulation modalities will also be collected. Trial registration: This protocol is registered at ClinicalTrials.gov under the number NCT06339632.
- 27 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0347493
Open AccessEffects of transcutaneous electrical phrenic nerve stimulation and transcutaneous electrical diaphragmatic stimulation: A protocol for a randomized, single-blind, crossover trial
Background: Patients in the intensive care unit (ICU) are at high risk of developing respiratory muscle weakness, which may lead to prolonged mechanical ventilation and worsening clinical outcomes. Noninvasive neuromuscular electrical stimulation techniques, such as transcutaneous electrical phrenic nerve stimulation (TEPNS) and transcutaneous diaphragmatic electrical stimulation (TDES), offer potential therapeutic options for patients unable to generate voluntary active contractions. However, there is limited research directly comparing the effects of these modalities on diaphragmatic function. The primary objective of this study is to evaluate the effects of TEPNS and TDES on diaphragmatic function in healthy adults. Secondary objectives include assessing the safety, feasibility, and perceived discomfort associated with the application of each technique. Methods: This study will be a bicentric, randomized, single-blind, crossover trial that will be conducted at two hospitals in São Paulo, Brazil. Healthy adults aged 18–60, with a BMI between 18.5 and 24.9 kg/m 2 , no history of respiratory diseases, and no contraindications for the proposed electrical stimulation modalities will be included. Diaphragm thickness, thickening fraction, and mobility will be assessed using ultrasound during tidal breathing. Participants will be randomly assigned to begin the intervention with one of two experimental conditions: (1) TEPNS protocol or (2) TDES protocol. In addition, data on the safety and feasibility of each electrical stimulation modalities will also be collected. Trial registration: This protocol is registered at ClinicalTrials.gov under the number NCT06339632.
- 24 December 2025
- Published by Oxford University Press (OUP) in Physical Therapy
- Vol. 106 (1)
Association Between Timing of Out-of-Bed Mobilization and Functional Outcomes at Intensive Care Unit Discharge in Patients With COVID-19: An Analysis of Potential Clinical Reference Points
Importance: In patients who are critically ill, functional dependence and muscle weakness may be influenced by side effects related to the timing of out-of-bed mobilization, but there is a knowledge gap regarding the impact of exercise prescriptions in specific intensive care unit (ICU) populations. Objective: The objective of this study was to determine clinical reference values for the time to start out-of-bed mobilization of patients in the ICU to avoid functional dependence and muscle weakness at ICU discharge. Design: This study was a secondary analysis of a prospective multicenter cohort. Setting: The settings were the ICUs of 5 Brazilian hospitals. Participants: The participants were adult patients with COVID-19, an ICU stay of ≥4 days, and prior functional independence. Exposure: Time for out-of-bed mobilization was the first day the patient was mobilized to higher postures, provided there were no contraindications. Main outcomes and measures: Functional status (Barthel Index [BI]) and muscle strength (Medical Research Council Scale [MRC]) were assessed within 2 days of ICU discharge. Receiver operating characteristic analysis identified clinical thresholds for days to initiate out-of-bed mobilization in association with 2 levels of functional dependence and muscle weakness. Optimal cutoffs were based on sensitivity, specificity, and area under the curve (AUC). Results: A total of 339 patients (58 years old [SD = 46-66 years old]; Simplified Acute Physiology Score III = 51.3 [SD = 16.5]; 36% women; 53% on mechanical ventilation) were analyzed. Days to start out-of-bed mobilization for each outcome were as follows: 3 days for a BI of <85 points (sensitivity = 67%, specificity = 65%, AUC = 0.68 [95% CI = 0.63-0.74]); 4 days for a BI of <60 points (sensitivity = 60%, specificity = 65%, AUC = 0.66 [95% CI = 0.59-0.73]); 5 days for an MRC score of <48 points (sensitivity = 54%, specificity = 73%, AUC = 0.66 [95% CI = 0.59-0.73]); and 5 days for an MRC score of <36 points (sensitivity = 69%, specificity = 67%, AUC = 0.67 [95% CI = 0.49-0.85]). Conclusions: Early out-of-bed mobilization, initiated within 3 to 5 days of physiological readiness, may differentiate patients who develop functional dependence or ICU-acquired weakness at ICU discharge from those who do not. However, since discrimination ranged from 66% to 68%, with a narrow margin for worse outcomes, this recommendation should be interpreted within context. Relevance: Knowing clinical reference points for days to initiate out-of-bed exercises may help minimize poor physical outcomes at ICU discharge.
- 24 December 2025
- Published by Oxford University Press (OUP) in Physical Therapy
- Vol. 106 (1)
Association Between Timing of Out-of-Bed Mobilization and Functional Outcomes at Intensive Care Unit Discharge in Patients With COVID-19: An Analysis of Potential Clinical Reference Points
Importance: In patients who are critically ill, functional dependence and muscle weakness may be influenced by side effects related to the timing of out-of-bed mobilization, but there is a knowledge gap regarding the impact of exercise prescriptions in specific intensive care unit (ICU) populations. Objective: The objective of this study was to determine clinical reference values for the time to start out-of-bed mobilization of patients in the ICU to avoid functional dependence and muscle weakness at ICU discharge. Design: This study was a secondary analysis of a prospective multicenter cohort. Setting: The settings were the ICUs of 5 Brazilian hospitals. Participants: The participants were adult patients with COVID-19, an ICU stay of ≥4 days, and prior functional independence. Exposure: Time for out-of-bed mobilization was the first day the patient was mobilized to higher postures, provided there were no contraindications. Main outcomes and measures: Functional status (Barthel Index [BI]) and muscle strength (Medical Research Council Scale [MRC]) were assessed within 2 days of ICU discharge. Receiver operating characteristic analysis identified clinical thresholds for days to initiate out-of-bed mobilization in association with 2 levels of functional dependence and muscle weakness. Optimal cutoffs were based on sensitivity, specificity, and area under the curve (AUC). Results: A total of 339 patients (58 years old [SD = 46-66 years old]; Simplified Acute Physiology Score III = 51.3 [SD = 16.5]; 36% women; 53% on mechanical ventilation) were analyzed. Days to start out-of-bed mobilization for each outcome were as follows: 3 days for a BI of <85 points (sensitivity = 67%, specificity = 65%, AUC = 0.68 [95% CI = 0.63-0.74]); 4 days for a BI of <60 points (sensitivity = 60%, specificity = 65%, AUC = 0.66 [95% CI = 0.59-0.73]); 5 days for an MRC score of <48 points (sensitivity = 54%, specificity = 73%, AUC = 0.66 [95% CI = 0.59-0.73]); and 5 days for an MRC score of <36 points (sensitivity = 69%, specificity = 67%, AUC = 0.67 [95% CI = 0.49-0.85]). Conclusions: Early out-of-bed mobilization, initiated within 3 to 5 days of physiological readiness, may differentiate patients who develop functional dependence or ICU-acquired weakness at ICU discharge from those who do not. However, since discrimination ranged from 66% to 68%, with a narrow margin for worse outcomes, this recommendation should be interpreted within context. Relevance: Knowing clinical reference points for days to initiate out-of-bed exercises may help minimize poor physical outcomes at ICU discharge.
- 12 November 2025
- Published by Wiley in Physiotherapy Research International
- Vol. 31 (1) , e70127
Acute Effect of Intradialytic Aerobic Exercise on Cardiac Stunning in Patients With Chronic Kidney Disease: A Systematic Review and Meta‐Analysis
Background and Purpose: Intradialytic aerobic exercise (IAE) has emerged as a possible cardioprotective strategy for patients with chronic kidney disease (CKD). However, there is still no summary of the IAE prescription variables and their acute effect on reducing cardiac stunning in patients undergoing hemodialysis (HD). The aim of this review was to analyze the effect of a single IAE session compared to the HD without exercise on cardiac stunning in patients with CKD. Methods: Non‐randomized intervention studies, crossover trials, and randomized controlled trials involving patients with CKD undergoing HD were included. The primary outcomes were regional wall motion abnormalities (RWMA) and global longitudinal strain (GLS). The search was conducted on April 5, 2024 in eight databases. Studies in English, Portuguese, or Spanish were included with no date restriction. The Physiotherapy Evidence Database scale and the Cochrane collaboration risk of bias tool were used. Meta‐analyses were performed using RevMan version 5.4 with random‐effects models, reporting mean difference (MD) and 95% confidence interval (95% CI). Results: Three studies were included, totaling 97 patients (67 males). In echocardiography performed near the end of the HD session, IAE favored a reduction in the RWMA compared to the HD without exercise (MD −1.86 segments, 95% CI −3.09 to −0.62, p = 0.003). However, the decline in GLS at the end of the exercise (MD −0.50%, 95% CI −1.56 to 0.56, p = 0.35), and near the end of the HD session (MD −0.86%, 95% CI −1.85 to 0.14, p = 0.09) was not affected. Discussion: A single session of IAE can reduce RWMA at the end of the HD session, compared to the HD session without exercise. No significant effect on GLS was observed. The data supporting these findings are of low methodological quality and have a high risk of bias. Trial Registration: This systematic review was registered in PROSPERO (CRD42024496368)
- 12 November 2025
- Published by Wiley in Physiotherapy Research International
- Vol. 31 (1) , e70127
Acute Effect of Intradialytic Aerobic Exercise on Cardiac Stunning in Patients With Chronic Kidney Disease: A Systematic Review and Meta‐Analysis
Background and Purpose: Intradialytic aerobic exercise (IAE) has emerged as a possible cardioprotective strategy for patients with chronic kidney disease (CKD). However, there is still no summary of the IAE prescription variables and their acute effect on reducing cardiac stunning in patients undergoing hemodialysis (HD). The aim of this review was to analyze the effect of a single IAE session compared to the HD without exercise on cardiac stunning in patients with CKD. Methods: Non‐randomized intervention studies, crossover trials, and randomized controlled trials involving patients with CKD undergoing HD were included. The primary outcomes were regional wall motion abnormalities (RWMA) and global longitudinal strain (GLS). The search was conducted on April 5, 2024 in eight databases. Studies in English, Portuguese, or Spanish were included with no date restriction. The Physiotherapy Evidence Database scale and the Cochrane collaboration risk of bias tool were used. Meta‐analyses were performed using RevMan version 5.4 with random‐effects models, reporting mean difference (MD) and 95% confidence interval (95% CI). Results: Three studies were included, totaling 97 patients (67 males). In echocardiography performed near the end of the HD session, IAE favored a reduction in the RWMA compared to the HD without exercise (MD −1.86 segments, 95% CI −3.09 to −0.62, p = 0.003). However, the decline in GLS at the end of the exercise (MD −0.50%, 95% CI −1.56 to 0.56, p = 0.35), and near the end of the HD session (MD −0.86%, 95% CI −1.85 to 0.14, p = 0.09) was not affected. Discussion: A single session of IAE can reduce RWMA at the end of the HD session, compared to the HD session without exercise. No significant effect on GLS was observed. The data supporting these findings are of low methodological quality and have a high risk of bias. Trial Registration: This systematic review was registered in PROSPERO (CRD42024496368)
- Open Access
- 28 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-8
Point-of-care kinesiological ultrasound certification process based on statistical and clinical criteria for skeletal muscle assessment
Intensive care unit patients often experience significant muscle mass loss, necessitating precise monitoring to guide interventions. Training and certifying physiotherapists help ensure agreement in measurements, reducing errors during assessments. The objective of this study is to certify a team of physiotherapists using both statistical and clinical criteria to ensure consistent ultrasound measurements of muscle architecture. This observational study evaluated the Kinesiological Muscle Ultrasound VISA certification program for physiotherapists. The program included three hours of theoretical instruction and three hours of supervised practice. Certification was granted based on both clinical and statistical criteria, with measurement agreement analyzed using the Bland-Altman method. Three training cycles were required to certify all physiotherapists. Notably, only 63% of measurements that satisfied the statistical criterion also met the clinical criteria. At the conclusion of the training program, the mean differences between expert and trainee measurements were: -0.05 cm (95% CI: -0.08 to -0.01) for right vastus intermedius thickness, -0.06 cm (95% CI: -0.09 to -0.03) for left vastus intermedius thickness, -0.06 cm (95% CI: -0.08 to -0.04) for right rectus femoris thickness, -0.02 cm (95% CI: -0.05 to 0.008) for left rectus femoris thickness, 0.009 cm² (95% CI: -0.05 to 0.07) for the right cross-sectional area, and − 0.09 cm² (95% CI: -0.16 to -0.01) for the left cross-sectional area of the rectus femoris. Employing both statistical and clinical criteria, along with agreement analysis between expert and trainee measurements, was a pivotal strategy for addressing the training needs of physiotherapists.
- 28 October 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-8
Open AccessPoint-of-care kinesiological ultrasound certification process based on statistical and clinical criteria for skeletal muscle assessment
Intensive care unit patients often experience significant muscle mass loss, necessitating precise monitoring to guide interventions. Training and certifying physiotherapists help ensure agreement in measurements, reducing errors during assessments. The objective of this study is to certify a team of physiotherapists using both statistical and clinical criteria to ensure consistent ultrasound measurements of muscle architecture. This observational study evaluated the Kinesiological Muscle Ultrasound VISA certification program for physiotherapists. The program included three hours of theoretical instruction and three hours of supervised practice. Certification was granted based on both clinical and statistical criteria, with measurement agreement analyzed using the Bland-Altman method. Three training cycles were required to certify all physiotherapists. Notably, only 63% of measurements that satisfied the statistical criterion also met the clinical criteria. At the conclusion of the training program, the mean differences between expert and trainee measurements were: -0.05 cm (95% CI: -0.08 to -0.01) for right vastus intermedius thickness, -0.06 cm (95% CI: -0.09 to -0.03) for left vastus intermedius thickness, -0.06 cm (95% CI: -0.08 to -0.04) for right rectus femoris thickness, -0.02 cm (95% CI: -0.05 to 0.008) for left rectus femoris thickness, 0.009 cm² (95% CI: -0.05 to 0.07) for the right cross-sectional area, and − 0.09 cm² (95% CI: -0.16 to -0.01) for the left cross-sectional area of the rectus femoris. Employing both statistical and clinical criteria, along with agreement analysis between expert and trainee measurements, was a pivotal strategy for addressing the training needs of physiotherapists.
- Open Access
- 11 October 2025
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 107 (5) , 955-964
Discriminatory Characteristics of Responders and Nonresponders of Patients With Sepsis to Neuromuscular Electrical Stimulation: A Subanalysis of a Randomized Controlled Double-Blinded Trial
- 11 October 2025
- Published by Elsevier in Archives of Physical Medicine and Rehabilitation
- Vol. 107 (5) , 955-964
Open AccessDiscriminatory Characteristics of Responders and Nonresponders of Patients With Sepsis to Neuromuscular Electrical Stimulation: A Subanalysis of a Randomized Controlled Double-Blinded Trial
- Open Access
- 2 February 2024
- Published by Springer Nature in BMC Sports Science, Medicine and Rehabilitation
- Vol. 16 (1) , 1-9
The phase angle cut-off point capable of discriminating hemodialysis patients with reduced exercise tolerance: a cross-sectional study
Background: Phase angle (PhA) is a prognostic marker of all-cause mortality in chronic kidney disease. However, no study has investigated this marker as a predictor of exercise intolerance in hemodialysis (HD) patients. The aim of this study was to determine a cut-off point for the PhA capable of discriminating HD patients with reduced exercise tolerance. Methods: Thirty-one patients (80.6% men, median age 69 years) were included. The evaluations were performed on three different days, before the HD session. The outcomes evaluated were: biochemical markers, inflammatory and nutritional status, body composition, peripheral muscle strength and exercise tolerance. Performance ≤50% of the predicted value in the six-minute step test (6MST) was defined as reduced exercise tolerance. Results: Patients presented an average of 67.6 steps (50.5% of predicted) in the 6MST. Fifteen patients (48.4%) were classified with reduced exercise tolerance. The receiver operating characteristic curve indicated a cut-off point of 3.73° for the PhA (sensitivity = 87%, specificity = 81%, and area under the curve = 0.88 [95% CI: 0.76–1.00]; p < 0.001). Patients with reduced exercise tolerance had worse inflammatory and nutritional status, lower PhA and greater impairment of peripheral muscle strength. Conclusion: The cut-off point of 3.73° for the PhA is sensitive and specific to discriminate HD patients with reduced exercise tolerance. Trial registration: This study was registered in the Clinical Trials database (no. NCT03779126, date of first registration 19/12/2018).
- 2 February 2024
- Published by Springer Nature in BMC Sports Science, Medicine and Rehabilitation
- Vol. 16 (1) , 1-9
Open AccessThe phase angle cut-off point capable of discriminating hemodialysis patients with reduced exercise tolerance: a cross-sectional study
Background: Phase angle (PhA) is a prognostic marker of all-cause mortality in chronic kidney disease. However, no study has investigated this marker as a predictor of exercise intolerance in hemodialysis (HD) patients. The aim of this study was to determine a cut-off point for the PhA capable of discriminating HD patients with reduced exercise tolerance. Methods: Thirty-one patients (80.6% men, median age 69 years) were included. The evaluations were performed on three different days, before the HD session. The outcomes evaluated were: biochemical markers, inflammatory and nutritional status, body composition, peripheral muscle strength and exercise tolerance. Performance ≤50% of the predicted value in the six-minute step test (6MST) was defined as reduced exercise tolerance. Results: Patients presented an average of 67.6 steps (50.5% of predicted) in the 6MST. Fifteen patients (48.4%) were classified with reduced exercise tolerance. The receiver operating characteristic curve indicated a cut-off point of 3.73° for the PhA (sensitivity = 87%, specificity = 81%, and area under the curve = 0.88 [95% CI: 0.76–1.00]; p < 0.001). Patients with reduced exercise tolerance had worse inflammatory and nutritional status, lower PhA and greater impairment of peripheral muscle strength. Conclusion: The cut-off point of 3.73° for the PhA is sensitive and specific to discriminate HD patients with reduced exercise tolerance. Trial registration: This study was registered in the Clinical Trials database (no. NCT03779126, date of first registration 19/12/2018).
- Open Access
- 20 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0279269
Hemodynamic impact of early mobilization in critical patients receiving vasoactive drugs: A prospective cohort study
Background: Vasoactive drugs are one of the most common patient-related barriers to early mobilization. Little is known about the hemodynamic effects of early mobilization on patients receiving vasoactive drugs. This study aims to observe and describe the impact of mobilization on the vital signs of critical patients receiving vasoactive drugs as well as the occurrence of adverse events. Methods: This is a cohort study performed in an Intensive Care Unit with patients receiving vasoactive drugs. All patients, either mobilized or non-mobilized, had their clinical data such as vital signs [heart rate, respiratory rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, and oxygen saturation], type and dosage of the vasoactive drug, and respiratory support collected at rest. For mobilized patients, the vital signs were also collected after mobilization, and so was the highest level of mobility achieved and the occurrence of adverse events. The criteria involved in the decision of mobilizing the patients were registered. Results: 53 patients were included in this study and 222 physiotherapy sessions were monitored. In most of the sessions (n = 150, 67.6%), patients were mobilized despite the use of vasoactive drugs. There was a statistically significant increase in heart rate and respiratory rate after mobilization when compared to rest (p<0.05). Only two (1.3%) out of 150 mobilizations presented an adverse event. Most of the time, non-mobilizations were justified by the existence of a clinical contraindication (n = 61, 84.7%). Conclusions: The alterations observed in the vital signs of mobilized patients may have reflected physiological adjustments of patients’ cardiovascular and respiratory systems to the increase in physical demand imposed by the early mobilization. The adverse events were rare, not serious, and reversed through actions such as a minimal increase of the vasoactive drug dosage.
- 20 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0279269
Open AccessHemodynamic impact of early mobilization in critical patients receiving vasoactive drugs: A prospective cohort study
Background: Vasoactive drugs are one of the most common patient-related barriers to early mobilization. Little is known about the hemodynamic effects of early mobilization on patients receiving vasoactive drugs. This study aims to observe and describe the impact of mobilization on the vital signs of critical patients receiving vasoactive drugs as well as the occurrence of adverse events. Methods: This is a cohort study performed in an Intensive Care Unit with patients receiving vasoactive drugs. All patients, either mobilized or non-mobilized, had their clinical data such as vital signs [heart rate, respiratory rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, and oxygen saturation], type and dosage of the vasoactive drug, and respiratory support collected at rest. For mobilized patients, the vital signs were also collected after mobilization, and so was the highest level of mobility achieved and the occurrence of adverse events. The criteria involved in the decision of mobilizing the patients were registered. Results: 53 patients were included in this study and 222 physiotherapy sessions were monitored. In most of the sessions (n = 150, 67.6%), patients were mobilized despite the use of vasoactive drugs. There was a statistically significant increase in heart rate and respiratory rate after mobilization when compared to rest (p<0.05). Only two (1.3%) out of 150 mobilizations presented an adverse event. Most of the time, non-mobilizations were justified by the existence of a clinical contraindication (n = 61, 84.7%). Conclusions: The alterations observed in the vital signs of mobilized patients may have reflected physiological adjustments of patients’ cardiovascular and respiratory systems to the increase in physical demand imposed by the early mobilization. The adverse events were rare, not serious, and reversed through actions such as a minimal increase of the vasoactive drug dosage.
- Open Access
Efficacy of neuromuscular electrical stimulation with combined low and high frequencies on body composition, peripheral muscle function and exercise tolerance in patients with chronic kidney disease undergoing haemodialysis: a protocol for a randomised, double-blind clinical trial
Introduction Neuromuscular electrical stimulation (NMES) as an adjunctive strategy to increase isolated muscular strength or endurance has been widely investigated in patients with chronic kidney disease (CKD) undergoing haemodialysis (HD). However, the efficacy of combined low and high frequencies, to improve both muscular strength and endurance, is unknown. This trial aims to evaluate the efficacy of this combined NMES strategy in this population. Methods and analysis This is a randomised controlled trial with blinded assessments and analysis. A total of 56 patients with CKD undergoing HD will be recruited and randomised to an NMES protocol. The evaluations will be performed on three different days at baseline and after 24 sessions of follow-up. Assessments will include the background, insulin-like growth factor, lactate measurement, malnutrition and inflammation score evaluation, an electrical bioimpedance examination, global muscular evaluation by means of the Medical Research Council scale, handgrip strength evaluation, muscular isokinetic evaluation of lower limbs, 6 min step test performance and quality of life (QoL) questionnaire with emphasis on physical function. The patients will be allocated in one of the following four groups: 1) combined low and high frequencies; 2) low frequency; 3) high frequency; and 4) sham stimulation with minimal intensity to generate only sensory perception (with no visible contraction). In all groups, the intensity throughout the session will be the highest tolerated by patient (except for control group). The primary endpoint is the change of peripheral muscle function (muscular strength and endurance). The secondary endpoints will be the changes of body composition; muscle trophism; exercise tolerance; QoL; and nutritional, inflammatory, and metabolic markers. The findings of this study are expected to provide valuable knowledge on how to optimise the NMES intervention, with improvements in both muscle strength and endurance. Ethics and dissemination This protocol has been approved by the Ethics Committee on Research with Humans of Hospital Sírio-Libanês (approval no. 24337707). Written informed consent will be obtained from each participant. The results of the study will be published in peer-reviewed journals. Trial registration number NCT03779126
Open AccessEfficacy of neuromuscular electrical stimulation with combined low and high frequencies on body composition, peripheral muscle function and exercise tolerance in patients with chronic kidney disease undergoing haemodialysis: a protocol for a randomised, double-blind clinical trial
Introduction Neuromuscular electrical stimulation (NMES) as an adjunctive strategy to increase isolated muscular strength or endurance has been widely investigated in patients with chronic kidney disease (CKD) undergoing haemodialysis (HD). However, the efficacy of combined low and high frequencies, to improve both muscular strength and endurance, is unknown. This trial aims to evaluate the efficacy of this combined NMES strategy in this population. Methods and analysis This is a randomised controlled trial with blinded assessments and analysis. A total of 56 patients with CKD undergoing HD will be recruited and randomised to an NMES protocol. The evaluations will be performed on three different days at baseline and after 24 sessions of follow-up. Assessments will include the background, insulin-like growth factor, lactate measurement, malnutrition and inflammation score evaluation, an electrical bioimpedance examination, global muscular evaluation by means of the Medical Research Council scale, handgrip strength evaluation, muscular isokinetic evaluation of lower limbs, 6 min step test performance and quality of life (QoL) questionnaire with emphasis on physical function. The patients will be allocated in one of the following four groups: 1) combined low and high frequencies; 2) low frequency; 3) high frequency; and 4) sham stimulation with minimal intensity to generate only sensory perception (with no visible contraction). In all groups, the intensity throughout the session will be the highest tolerated by patient (except for control group). The primary endpoint is the change of peripheral muscle function (muscular strength and endurance). The secondary endpoints will be the changes of body composition; muscle trophism; exercise tolerance; QoL; and nutritional, inflammatory, and metabolic markers. The findings of this study are expected to provide valuable knowledge on how to optimise the NMES intervention, with improvements in both muscle strength and endurance. Ethics and dissemination This protocol has been approved by the Ethics Committee on Research with Humans of Hospital Sírio-Libanês (approval no. 24337707). Written informed consent will be obtained from each participant. The results of the study will be published in peer-reviewed journals. Trial registration number NCT03779126
- Open Access
- 24 June 2022
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 13, 853434
The Six-Minute Stepper Test Is Valid to Evaluate Functional Capacity in Hospitalized Patients With Exacerbated COPD
Background: The six-minute stepper test (6MST) is a self-paced test considered a valid tool to assess functional capacity in stable COPD patients. However, a high floor effect, where a large proportion of participants reach the minimum score when using the measurement instrument, might compromise the test validity in the hospital setting. Therefore, this study aimed at verifying the concurrent validity of 6MST in hospitalized patients with acute exacerbation of COPD (AECOPD).Methods: A cross-sectional study was conducted in a tertiary hospital. Patients who were hospitalized due to AECOPD were considered for inclusion. On the first day, when patients reached minimum clinical criteria considered as the use of non-invasive ventilation less than 2 h for 6 h/period, dyspnea at rest less than 7 (very severe) on the modified Borg scale, a respiratory rate less than 25 breaths per minute, oxygen pulse saturation greater than 88% (considering use of supplemental oxygen) and absence of paradoxical breathing pattern, they underwent a lung function evaluation and answered three questionnaires: Chronic Respiratory Questionnaire (CRQ), Modified Medical Research Council Dyspnea Scale (MMRC), and COPD Assessment Test (CAT). Then, on two consecutive days, patients performed 6MST or six-minute walk test (6MWT), in random order. Each test was performed twice, and the best performance was recorded. Also, the patient’s severity was classified according to the BODE index. Inspiratory capacity measurements were performed before and after each test execution.Results: Sixteen patients (69.4 ± 11.4 years) with a mean FEV₁ of 49.4 ± 9.9% predicted were included (9 females). There was a strong correlation of the performance in 6MST (number of cycles) with 6MWT (distance walked in meters) in absolute values (r = 0.87, p < 0.001) as well as with the percentage of predicted normal 6MWT (r = 0.86, p < 0.001). There was a strong correlation between the performance in 6MST with the dynamic hyperinflation (r = 0.72, p = 0.002) and a moderate correlation between 6MST with the percentage of reduction of inspiratory capacity (r = 0.68, p = 0.004). We also identified that 6MST showed moderate negative correlations with CAT (r = −0.62, p = 0.01) and BODE index (r = −0.59, p = 0.01).Conclusion: It could be concluded that 6MST is valid for evaluating functional capacity in hospitalized patients with exacerbated COPD.
- 24 June 2022
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 13, 853434
Open AccessThe Six-Minute Stepper Test Is Valid to Evaluate Functional Capacity in Hospitalized Patients With Exacerbated COPD
Background: The six-minute stepper test (6MST) is a self-paced test considered a valid tool to assess functional capacity in stable COPD patients. However, a high floor effect, where a large proportion of participants reach the minimum score when using the measurement instrument, might compromise the test validity in the hospital setting. Therefore, this study aimed at verifying the concurrent validity of 6MST in hospitalized patients with acute exacerbation of COPD (AECOPD).Methods: A cross-sectional study was conducted in a tertiary hospital. Patients who were hospitalized due to AECOPD were considered for inclusion. On the first day, when patients reached minimum clinical criteria considered as the use of non-invasive ventilation less than 2 h for 6 h/period, dyspnea at rest less than 7 (very severe) on the modified Borg scale, a respiratory rate less than 25 breaths per minute, oxygen pulse saturation greater than 88% (considering use of supplemental oxygen) and absence of paradoxical breathing pattern, they underwent a lung function evaluation and answered three questionnaires: Chronic Respiratory Questionnaire (CRQ), Modified Medical Research Council Dyspnea Scale (MMRC), and COPD Assessment Test (CAT). Then, on two consecutive days, patients performed 6MST or six-minute walk test (6MWT), in random order. Each test was performed twice, and the best performance was recorded. Also, the patient’s severity was classified according to the BODE index. Inspiratory capacity measurements were performed before and after each test execution.Results: Sixteen patients (69.4 ± 11.4 years) with a mean FEV₁ of 49.4 ± 9.9% predicted were included (9 females). There was a strong correlation of the performance in 6MST (number of cycles) with 6MWT (distance walked in meters) in absolute values (r = 0.87, p < 0.001) as well as with the percentage of predicted normal 6MWT (r = 0.86, p < 0.001). There was a strong correlation between the performance in 6MST with the dynamic hyperinflation (r = 0.72, p = 0.002) and a moderate correlation between 6MST with the percentage of reduction of inspiratory capacity (r = 0.68, p = 0.004). We also identified that 6MST showed moderate negative correlations with CAT (r = −0.62, p = 0.01) and BODE index (r = −0.59, p = 0.01).Conclusion: It could be concluded that 6MST is valid for evaluating functional capacity in hospitalized patients with exacerbated COPD.
- Open Access
- 25 May 2022
- Published by Associacao Brasileira da Rede Unida in CADERNOS DE EDUCAÇÃO, SAÚDE E FISIOTERAPIA
- Vol. 9 (19)
INFLUÊNCIA DA RESERVA VENTILATÓRIA NA MOBILIDADE DIAFRAGMÁTICA EM PACIENTES COM DOENÇA PULMONAR OBSTRUTIVA CRÔNICA
Objetivo: Investigar a influência da reserva ventilatória (RV) na mobilidade diafragmática (MD) em pacientes com doença pulmonar obstrutiva crônica (DPOC), bem como comparar as características antropométricas, função pulmonar, MD, dispneia e capacidade de exercício entre os grupos RV >11litros/minuto (l/min) e RV 11litros/minuto (l/min) e RV <11l/min para comparação entre os grupos. Resultados: A RV influenciou em 25% a MD (p=0,001, F=13,78). Ao comparar os grupos RV ? 11l/min e RV ? 11l/min, constatou-se que no grupo RV ?11l/min os pacientes apresentaram redução das variáveis: capacidade inspiratória (CI), volume expiratório forçado no primeiro segundo (VEF1), MD, pior capacidade submáxima de exercício e maior dispneia. Conclusões: A RV influencia a MD. Além disso, o grupo RV <11l/min foi mais comprometido tanto na função pulmonar e MD quanto na capacidade submáxima de exercício e dispneia.
- 25 May 2022
- Published by Associacao Brasileira da Rede Unida in CADERNOS DE EDUCAÇÃO, SAÚDE E FISIOTERAPIA
- Vol. 9 (19)
Open AccessINFLUÊNCIA DA RESERVA VENTILATÓRIA NA MOBILIDADE DIAFRAGMÁTICA EM PACIENTES COM DOENÇA PULMONAR OBSTRUTIVA CRÔNICA
Objetivo: Investigar a influência da reserva ventilatória (RV) na mobilidade diafragmática (MD) em pacientes com doença pulmonar obstrutiva crônica (DPOC), bem como comparar as características antropométricas, função pulmonar, MD, dispneia e capacidade de exercício entre os grupos RV >11litros/minuto (l/min) e RV 11litros/minuto (l/min) e RV <11l/min para comparação entre os grupos. Resultados: A RV influenciou em 25% a MD (p=0,001, F=13,78). Ao comparar os grupos RV ? 11l/min e RV ? 11l/min, constatou-se que no grupo RV ?11l/min os pacientes apresentaram redução das variáveis: capacidade inspiratória (CI), volume expiratório forçado no primeiro segundo (VEF1), MD, pior capacidade submáxima de exercício e maior dispneia. Conclusões: A RV influencia a MD. Além disso, o grupo RV <11l/min foi mais comprometido tanto na função pulmonar e MD quanto na capacidade submáxima de exercício e dispneia.